Book contents
- Frontmatter
- Contents
- List of Figures
- List of Tables
- List of Contributors
- Introduction
- PART I ADVANCES IN GPCR PROTEIN RESEARCH
- PART II OLIGOMERIZATION OF GPCRS
- PART III GPCR SIGNALING FEATURES
- 7 G protein functions identified using genetic mouse models
- 8 Kinetics of GPCR, G protein, and effector activation
- 9 RGS-RhoGEFs and other RGS multidomain proteins as effector molecules in GPCR-dependent and GPCR-independent cell signaling
- 10 Adenylyl cyclase isoform-specific signaling of GPCRs
- 11 G protein-independent and β arrestin-dependent GPCR signaling
- 12 Assays to read GPCR modulation and signaling
- PART IV LIGAND PHARMACOLOGY OF GPCRS
- PART V PHYSIOLOGICAL FUNCTIONS AND DRUG TARGETING OF GPCRS
- Index
- References
10 - Adenylyl cyclase isoform-specific signaling of GPCRs
from PART III - GPCR SIGNALING FEATURES
Published online by Cambridge University Press: 05 June 2012
Book contents
- Frontmatter
- Contents
- List of Figures
- List of Tables
- List of Contributors
- Introduction
- PART I ADVANCES IN GPCR PROTEIN RESEARCH
- PART II OLIGOMERIZATION OF GPCRS
- PART III GPCR SIGNALING FEATURES
- 7 G protein functions identified using genetic mouse models
- 8 Kinetics of GPCR, G protein, and effector activation
- 9 RGS-RhoGEFs and other RGS multidomain proteins as effector molecules in GPCR-dependent and GPCR-independent cell signaling
- 10 Adenylyl cyclase isoform-specific signaling of GPCRs
- 11 G protein-independent and β arrestin-dependent GPCR signaling
- 12 Assays to read GPCR modulation and signaling
- PART IV LIGAND PHARMACOLOGY OF GPCRS
- PART V PHYSIOLOGICAL FUNCTIONS AND DRUG TARGETING OF GPCRS
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- G Protein-Coupled ReceptorsStructure, Signaling, and Physiology, pp. 189 - 216Publisher: Cambridge University PressPrint publication year: 2010
References
and (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles, J. Biol. Chem. 232, 1077–1091.Google ScholarPubMed
and (2007) Adenylyl cyclase 5: a new clue in the search for the “fountain of youth”?, Sci STKE. 2007, e64.CrossRefGoogle ScholarPubMed
(2007) Adenylyl cyclase isoforms as novel therapeutic targets: an exciting example of excitotoxicity neuroprotection, Mol. Interv. 7, 70–73.CrossRefGoogle ScholarPubMed
and (2009) Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies, Neurosignals. 17, 5–22.CrossRefGoogle Scholar
, , , and (2009) The role of Gbetagamma subunits in the organization, assembly, and function of GPCR signaling complexes, Annu. Rev. Pharmacol. Toxicol. 49, 31–56.CrossRefGoogle ScholarPubMed
and (2007) Overview of PDEs and their regulation, Circ. Res. 100, 309–327.CrossRefGoogle ScholarPubMed
, , , , , , , , and (1989) Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure, Science 244, 1558–1564.CrossRefGoogle ScholarPubMed
, , , , and (1999) Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals, Proc. Natl. Acad. Sci. U. S. A 96, 79–84.CrossRefGoogle ScholarPubMed
and (2006) Regulatory properties of adenylate cyclases type 5 and 6: A progress report, Eur. J. Pharmacol. 535, 1–12.CrossRefGoogle ScholarPubMed
and (2007) Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains, Phyisiol. Rev. 87, 965–1010.CrossRefGoogle ScholarPubMed
and (2004) Novel regulatory properties of human type 9 adenylate cyclase (AC9), J. Pharmacol. Exp. Ther. 310, 108–115.CrossRefGoogle Scholar
and (2005) Galphaq potentiation of adenylate cyclase type 9 activity through a Ca2+/calmodulin-dependent pathway, Biochem. Pharmacol. 69, 1247–1256.CrossRefGoogle ScholarPubMed
, , , , and (2004) Differentiation-induced alterations in cyclic AMP signaling in the Cath.a Differentiated (CAD) neuronal cell line, J. Neurochem. 88, 1497–1508.CrossRefGoogle ScholarPubMed
, , , and (2006) Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain, J. Comp Neurol. 496, 684–697.CrossRefGoogle ScholarPubMed
, , , , and (2006) D(2) dopamine receptor-induced sensitization of adenylyl cyclase type 1 is Galpha(s) independent, Neuropharmacology 50, 576–584.CrossRefGoogle Scholar
(2000) Regulation of adenylyl cyclases in the central nervous system, Cellular Signalling 12, 195–204.CrossRefGoogle ScholarPubMed
, Best- , and (2000) Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase, Am. J. Physiol. Renal Physiol. 279, F400-F416.CrossRefGoogle ScholarPubMed
, , , and (2006) Cellular localisation of adenylyl cyclase: a post-genome perspective, Neurochem. Res. 31, 287–295.CrossRefGoogle ScholarPubMed
and (2004) Why calcium-stimulated adenylyl cyclases?, Physiology (Bethesda.) 19, 271–276.Google ScholarPubMed
(2009) Structural determinants involved in the formation and activation of G protein betagamma dimers, Neurosignals. 17, 82–99.CrossRefGoogle ScholarPubMed
, , , , and (2008) Regulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VII, J. Biol. Chem. 283, 23429–23439.CrossRefGoogle ScholarPubMed
, Jr. (1986) A model for receptor-regulated calcium entry, Cell Calcium 7, 1–12.CrossRefGoogle ScholarPubMed
, , , , , , , and (2009) Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8, Mol. Pharmacol. 75, 830–842.CrossRefGoogle ScholarPubMed
, , , and (1996) Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo, J. Biol. Chem. 271, 33308–33316.CrossRefGoogle ScholarPubMed
and (2001) Heterologous sensitization of recombinant adenylate cyclases by activation of D2 dopamine receptors, J. Pharmacol. Exp. Ther. 297, 1201–1209.Google Scholar
, , and (1993) Inhibition of adenylyl cyclase by Gi alpha, Science 261, 218–221.CrossRefGoogle ScholarPubMed
, , , and (2009) Distinct mechanisms of regulation by Ca2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles, J. Biol. Chem. 284, 4451–4463.CrossRefGoogle ScholarPubMed
, , , and (1992) Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells, J. Biol. Chem. 267, 12440–12442.Google ScholarPubMed
, , , , , and (1994) Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo, J. Biol. Chem. 269, 25400–25405.Google ScholarPubMed
, , , , , , , and (2003) Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts, J. Biol. Chem. 278, 24461–24468.CrossRefGoogle ScholarPubMed
, , Endo- , , , and (2000) Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s), Am. J. Physiol Cell Physiol 278, 154–162.CrossRefGoogle Scholar
, , , and (1993) Stimulation of specific types of GS-stimulated adenylyl cyclases by phorbol ester treatment, J. Biol. Chem. 268, 3829–3832.Google ScholarPubMed
and (1991) Type-specific regulation of adenylyl cyclase by G protein α subunits, Science 254, 1500–1502.CrossRefGoogle Scholar
, , , , and (1992) Hormonal stimulation of adenylyl cyclase through Gi-protein α subunits, Nature 356, 159–161.CrossRefGoogle Scholar
, , , and (1994) Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases, J. Biol. Chem. 269, 6093–6100.Google ScholarPubMed
, , , and (2003) Ethanol-induced phosphorylation and potentiation of the activity of type 7 adenylyl cyclase. Involvement of protein kinase C delta, J. Biol. Chem. 278, 4552–4560.CrossRefGoogle ScholarPubMed
and (1996) Gi-mediated stimulation of type II adenylyl cyclase is augmented by Gq-coupled receptor activation and phorbol ester treatment, J. Neurosci. 16, 1317–1323.CrossRefGoogle ScholarPubMed
and (1997) Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors, Mol. Pharmacol. 52, 181–186.CrossRefGoogle Scholar
and (2007) Targeting the protein kinase C family: are we there yet?, Nat. Rev. Cancer 7, 554–562.CrossRefGoogle ScholarPubMed
and (1996) Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits, J. Biol. Chem. 271, 27161–27166.CrossRefGoogle Scholar
and (2006) Dexamethasone-induced Ras protein 1 negatively regulates protein kinase C delta: implications for adenylyl cyclase 2 signaling, Mol. Pharmacol. 69, 1763–1771.CrossRefGoogle ScholarPubMed
, , , and (1994) Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells, J. Biol. Chem. 269, 28893–28898.Google ScholarPubMed
, , , , , and (1995) The characterization of a novel human adenylyl cyclase which is present in brain and other tissues, J. Biol. Chem. 270, 11581–11589.CrossRefGoogle ScholarPubMed
, , and (2000) Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domains, J. Biol. Chem. 275, 26530–26537.CrossRefGoogle ScholarPubMed
, , , and (2006) Calcium signals mediated by STIM and Orai proteins – a new paradigm in inter-organelle communication, Biochim. Biophys. Acta 1763, 1161–1168.CrossRefGoogle ScholarPubMed
, , , , , and (2009) Dependence of stim1/orai1 mediated calcium entry on plasma membrane phosphoinositides, J. Biol. Chem. 284, 21027–21035.CrossRefGoogle ScholarPubMed
, , , , , , and (1998) Inhibition of adenylyl cyclase isoforms V and VI by various Gβγ subunits, FASEB J. 12, 1019–1025.CrossRefGoogle ScholarPubMed
, , , and (2007) Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits, J. Biol. Chem. 282, 294–302.CrossRefGoogle ScholarPubMed
, , , and (2004) An important functional role of the N terminus domain of type VI adenylyl cyclase in Galphai-mediated inhibition, J. Biol. Chem. 279, 34440–34448.CrossRefGoogle Scholar
, , and (2005) Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells, Mol. Pharmacol. 67, 250–259.CrossRefGoogle ScholarPubMed
, , , , , , , , and (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation, Proc. Natl. Acad. Sci. U. S. A 94, 14100–14104.CrossRefGoogle Scholar
, , , , , and (1995) Regulation of adenylyl cyclase by protein kinase A, J. Biol. Chem. 270, 12481–12484.CrossRefGoogle ScholarPubMed
, , , , , , , and (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes, J. Biol. Chem. 269, 16554–16558.Google ScholarPubMed
and (2005) Galpha(q)-coupled receptor signaling enhances adenylate cyclase type 6 activation, Biochem. Pharmacol. 70, 113–120.CrossRefGoogle ScholarPubMed
, , , and (1998) Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase, Molecular Pharmacology 53, 182–187.CrossRefGoogle ScholarPubMed
, , , , , , and (2000) Characterization of human adenylyl cyclase IX reveals inhibition by Ca2+/calcineurin and differential mRNA polyadenylation, J. Neurochem. 75, 1358–1367.CrossRefGoogle Scholar
, , , , , , , and (1998) Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9), Genomics 50, 97–104.CrossRefGoogle Scholar
, , and (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance, Proc. Natl. Acad. Sci. U. S. A 72, 3092–3096.CrossRefGoogle ScholarPubMed
and (2005) Sensitization of adenylate cyclase by Galpha(i/o)-coupled receptors, Pharmacol Ther 106, 405–421.CrossRefGoogle ScholarPubMed
and (2006) Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3, J. Neurochem. 99, 1494–1504.CrossRefGoogle ScholarPubMed
, , , , and (2003) Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways., J. Biol. Chem. 278, 9418–9425.CrossRefGoogle ScholarPubMed
, , , , , and (1998) Selective activation of Gαo by D2L dopamine receptors in NS20Y neuroblastoma cells, J. Neurosci. 18, 8692–8699.CrossRefGoogle ScholarPubMed
, , , , and (2006) Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells, Mol. Pharmacol. 69, 1810–1819.CrossRefGoogle Scholar
and (2006) Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules, Life Sci 79, 717–722.CrossRefGoogle ScholarPubMed
, , and (2008) Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment, Mol. Pharmacol. 73, 868–879.CrossRefGoogle ScholarPubMed
and (2005) Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6, Cell Signal 17, 647–653.CrossRefGoogle ScholarPubMed
, , , , and (2009) Sustained morphine treatment augments capsaicin-evoked CGRP release from primary sensory neurons in a PKA and Raf-1- dependent manner, J. Pharmacol. Exp. Ther. In press.CrossRefGoogle Scholar
, , , , , and (2006) Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074, Eur. J. Pharmacol. 540, 57–59.CrossRefGoogle ScholarPubMed
and (2005) Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1, Biochem Biophys Res Commun 332, 913–920.CrossRefGoogle ScholarPubMed
, Avidor- , , , and (2005) Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers, J Mol Neurosci 27, 195–203.CrossRefGoogle ScholarPubMed
, , , and (2009) Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons, Mol. Pharmacol. In press.CrossRefGoogle ScholarPubMed
, , Avidor- , , and (2000) Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor, Mol. Pharmacol. 57, 746–752.CrossRefGoogle Scholar
and (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors, Mol. Pharmacol. 50, 966–976.Google ScholarPubMed
, , and (2006) Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure, Neuropharmacology 50, 998–1005.CrossRefGoogle ScholarPubMed
, , , and (2004) Using molecular tools to dissect the role of Gs in sensitization of AC1, Mol. Pharmacol. 66, 1617–1624.CrossRefGoogle ScholarPubMed
and (2007) Phosphorylation of Galphas influences its association with the micro-opioid receptor and is modulated by long-term morphine exposure, Mol. Pharmacol. 72, 753–760.CrossRefGoogle ScholarPubMed
, , and (1997) Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation, Biochim. Biophys. Acta 1358, 307–313.CrossRefGoogle ScholarPubMed
, , and (1996) Splice variants of type VIII adenylyl cyclase. Differences in glycosylation and regulation by Ca2+/calmodulin, J. Biol. Chem. 271, 1089–1095.CrossRefGoogle ScholarPubMed
, , and (1996) Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo, J. Biol. Chem. 271, 24231–24235.CrossRefGoogle ScholarPubMed
, , , , and (2001) N-Glycosylation and residues Asn805 and Asn890 are involved in the functional properties of type VI adenylyl cyclase, J. Biol. Chem. 276, 35450–35457.CrossRefGoogle ScholarPubMed
, , , and (1999) Adenylyl cyclase, a coincidence detector for nitric oxide, J. Biol. Chem. 274, 18887–18892.CrossRefGoogle ScholarPubMed
, , and (2000) Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6, Cell Signal. 12, 233–237.CrossRefGoogle Scholar
, , and Anand- (2009) Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK, Am. J. Physiol Heart Circ. Physiol 296, H1859-H1867.CrossRefGoogle Scholar
, , , and (1997) Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα GTPS, Science 278, 1907–1916.CrossRefGoogle Scholar
, , , and (1997) Structure of the adenylyl cyclase catalytic core, Nature 386, 247–253.CrossRefGoogle ScholarPubMed
, , and (1995) Truncation and alanine-scanning mutants of type I adenylyl cyclase, Biochemistry 34, 14563–14572.CrossRefGoogle ScholarPubMed
, , and F. (2002) Dimerization of mammalian adenylate cyclases, Eur. J. Biochem. 269, 413–421.CrossRefGoogle ScholarPubMed
, , , , and (2008) Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha s, Cell Signal 20, 480–492.CrossRefGoogle ScholarPubMed
, , , , , and (2008) Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction, J. Biol. Chem. 283, 24659–24672.CrossRefGoogle ScholarPubMed
, , , and (2000) Differential targeting of á-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae, J. Biol. Chem. 275, 41447–41457.CrossRefGoogle Scholar
, , and (2008) G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains, Handb. Exp. Pharmacol. 167 –184.Google Scholar
, , , , and (2009) Differential effect of membrane cholesterol removal on mu and delta opioid receptors: A parallel comparison of acute and chronic signaling to adenylyl cyclase, J. Biol. Chem. 284, 22108–22122.CrossRefGoogle ScholarPubMed
, , , and (2008) The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain, Proc Natl Acad Sci U S A 105, 13835–13840.CrossRefGoogle ScholarPubMed
and (2009) Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signaling, Mol. Pharmacol. 75, 733–739.CrossRefGoogle Scholar
, , , , and (2007) BRET analysis of GPCR oligomerization: newer does not mean better, Nat Methods 4, 3–4.CrossRefGoogle Scholar
, , , , and (2007) Signalling complexes associated with adenylyl cyclase II are assembled during their biosynthesis, Cell Signal 19, 481–489.CrossRefGoogle ScholarPubMed
, , and (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor, J. Pharmacol. Exp. Ther. 308, 880–886.CrossRefGoogle ScholarPubMed
, Blake- , , , and (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?, Mol. Pharmacol. 67, 1697–1704.CrossRefGoogle ScholarPubMed
, , , , , , , and (2004) Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal, J. Biol. Chem. 279, 35671–35678.CrossRefGoogle ScholarPubMed
, , , , , , and (2009) Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers, Mol. Pharmacol. 75, 843–854.CrossRefGoogle ScholarPubMed
, , , , , and (2008) Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization, Mol. Pharmacol. 74, 59–69.CrossRefGoogle ScholarPubMed
, , , , , , , , , , , , , , and (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum, J. Biol. Chem. 283, 26016–26025.CrossRefGoogle ScholarPubMed
, , and (2001) The G protein β subunit is a determinant in the coupling of Gs to the β1-adrenergic and A2a adenosine receptors, J. Biol. Chem. 276, 15801–15809.CrossRefGoogle Scholar
, , , , and (2005) Silencing the expression of multiple Gbeta-subunits eliminates signaling mediated by all four families of G proteins, Proc. Natl. Acad. Sci. U. S. A 102, 9493–9498.CrossRefGoogle ScholarPubMed
, , , , , , and (2001) Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase, J. Biol. Chem. 276, 39386–39393.CrossRefGoogle Scholar
, , , , , and (2003) Loss of G protein gamma 7 alters behavior and reduces striatal alphaolf level and cAMP production, J. Biol. Chem. 278, 6575–6579.CrossRefGoogle Scholar
, , , and (2009) Capturing adenylyl cyclases as potential drug targets, Nat. Rev. Drug Discov. 8, 321–335.CrossRefGoogle ScholarPubMed
, , , , , , , and (1995) Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice, Proc. Natl. Acad. Sci. U. S. A 92, 220–224.CrossRefGoogle ScholarPubMed
, , , , , , , , , , , and (2000) Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice, J Neurosci 20, 4809–4820.CrossRefGoogle ScholarPubMed
, , , , , , , and (1999) Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP, Neuron 23, 787–798.CrossRefGoogle ScholarPubMed
, , , , , and (2006) Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses, Mol. Pharmacol. 70, 1742–1749.CrossRefGoogle ScholarPubMed
, , , and (2000) Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine, Mol. Pharmacol. 58, 1011–1016.CrossRefGoogle ScholarPubMed
, , , , , , , , , and (2007) Type 5 adenylyl cyclase disruption increases longevity and protects against stress, Cell 130, 247–258.CrossRefGoogle ScholarPubMed
, , , , , , , , , , and (2000) Functional uncoupling of adenosine A2A receptors and reduced response to caffeine in mice lacking dopamine D2 receptors, J. Neurosci. 5949–5957.CrossRefGoogle Scholar
- 1
- Cited by